VisEn Medical, a developer of fluorescence technologies for in vivo imaging of biologic and molecular processes, yesterday announced that Markus Rudin, PhD, has joined its Scientific Advisory Board.
   
Rudin is professor of molecular imaging and functional pharmacology at both the University of Zürich and the ETH Zürich (Swiss Federal Institute of Technology), Switzerland, and formerly head of Imaging Technologies at Novartis.
   
VisEn also announced that Rudin laboratory at University ETH has adopted VisEn's portfolio of in vivo Fluorescence Probes and Fluorescence Molecular Tomography (FMT) imaging system, as cornerstones of their molecular imaging programs.